TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 92 filers reported holding TG THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 6.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $683,000 | -40.7% | 146,838 | -1.4% | 0.00% | 0.0% |
| Q3 2016 | $1,152,000 | +27.6% | 148,863 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $903,000 | -24.8% | 149,087 | +5.7% | 0.00% | -50.0% |
| Q1 2016 | $1,201,000 | -18.7% | 140,985 | +13.8% | 0.00% | 0.0% |
| Q4 2015 | $1,478,000 | +18.3% | 123,895 | +0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,249,000 | -40.0% | 123,886 | -1.2% | 0.00% | -33.3% |
| Q2 2015 | $2,081,000 | +60.0% | 125,443 | +49.2% | 0.00% | +50.0% |
| Q1 2015 | $1,301,000 | +5.3% | 84,061 | +7.7% | 0.00% | 0.0% |
| Q4 2014 | $1,236,000 | +68.9% | 78,034 | +13.7% | 0.00% | +100.0% |
| Q3 2014 | $732,000 | +15.1% | 68,610 | +1.3% | 0.00% | 0.0% |
| Q2 2014 | $636,000 | +87.6% | 67,740 | +37.9% | 0.00% | – |
| Q1 2014 | $339,000 | +105.5% | 49,105 | +16.0% | 0.00% | – |
| Q4 2013 | $165,000 | -22.5% | 42,330 | 0.0% | 0.00% | – |
| Q3 2013 | $213,000 | +10.4% | 42,330 | +40.4% | 0.00% | – |
| Q2 2013 | $193,000 | – | 30,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |